Biology of the adenomatous polyposis coli tumor suppressor

Journal of Clinical Oncology

Volumn 18, Issue 9, 2000, Pages 1967-1979

  Goss, Kathleen Heppner ^a   Groden, Joanna ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE; COLON POLYPOSIS; COLORECTAL CANCER; FAMILIAL DISEASE; GENE INACTIVATION; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0034098691     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.9.1967     Document Type: Article

References (122)

1. Hamilton SR, Liu B, Parsons RE, et al: The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847, 1995
2. Bodmer WF, Bailey CJ, Bodmer J, et al: Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614-616, 1987
3. Leppert M, Dobbs M, Scambler P, et al: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238:1411-1413, 1987
4. Joslyn G, Carlson M, Thliveris A, et al: Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66:601-613, 1991
5. Kinzler KW, Nilbert MC, Su LK, et al: Identification of FAP locus genes from chromosome 5q21. Science 253:661-665, 1991
6. Groden J, Thliveris A, Samowitz W, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600, 1991
7. Nishisho I, Nakamura Y, Miyoshi Y, et al: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665-669, 1991
8. Herrera L, Kakati S, Gibas L, et al: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25:473-476, 1986
9. Thliveris A, Albertsen H, Tuohy T, et al: Long-range physical map and deletion characterization of the 1100-kb NotI restriction fragment harboring the APC gene. Genomics 34:268-270, 1996
10. Thliveris A, Samowitz W, Matsunami N, et al: Demonstration of promoter activity and alternative splicing in the region 5′ to exon 1 of the APC gene. Cancer Res 54:2991-2995, 1994
11. Horii A, Nakatsuru S, Ichii S, et al: Multiple forms of the APC gene transcripts and their tissue-specific expression. Hum Mol Genet 2:283-287, 1993
12. Sulekova Z, Ballhausen WG: A novel coding exon of the human adenomatous polyposis coli gene. Hum Genet 96:469-471, 1995
13. Pyles RB, Santoro IM, Groden J, et al: Novel protein isoforms of the APC rumor suppressor in neural tissue. Oncogene 16:77-82, 1998
14. Santoro IM, Groden J: Alternative splicing of the APC gene and its association with terminal differentiation. Cancer Res 57:488-494, 1997
15. Soussi: APC mutation database. Available at: http://perso.curie.fr/Thierry.Soussi/APC.html. July, 1999
16. Groden J, Gelbert L, Thliveris A, et al: Mutational analysis of patients with adenomatous polyposis: Identical inactivating mutations in unrelated individuals. Am J Hum Genet 52:263-272, 1993
17. Laken SJ, Petersen GM, Gruber SB, et al: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17:79-83, 1997
18. Spirio LN, Samowitz W, Robertson J, et al: Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nature Genet 20:385-388, 1998
19. Brensinger JD, Laken SJ, Luce MC, et al: Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene. Gut 43:548-552, 1998
20. Olschwang S, Tiret A, Laurent-Puig P, et al: Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 75:959-968, 1993
21. Caspari R, Olschwang S, Friedl W, et al: Familial adenomatous polyposis: Desmoid tumors and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337-340, 1995
22. Ecoles DM, van der Luijt R, Breukel C, et al: Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 59:1193-1201, 1996
23. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87:159-170, 1996
24. Miyoshi Y, Nagase H, Ando H, et al: Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum Mol Genet 1:229-233, 1992
25. Powell SM, Zilz N, Beazer-Barclay Y, et al: APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237, 1992
26. Jen J, Powell SM, Papadopoulos N, et al: Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523-5526, 1994
27. Joslyn G, Richardson DS, White R, et al: Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci USA 90:11109-11113, 1993
28. Su LK, Johnson KA, Smith KJ, et al: Association between wild type and mutant APC gene products. Cancer Res 53:2728-2731, 1993
29. Mahmoud NN, Boolbol SK, Bilinski RT, et al: APC gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res 57:5045-5050, 1997
30. Dihlmann S, Gebert J, Siermann A, et al: Dominant negative effect of the APC1309 mutation: A possible explanation for genotype-phenotype correlations in familial adenomatous coli. Cancer Res 59:1857-1860, 1999
31. Solomon E, Voss R, Hall V, et al: Chromosome 5 allele loss in human colorectal carcinomas. Nature 328:616-619, 1987
32. Lindgren V, Bryke CR, Ozcelik T, et al: Phenotypic, cytogenetic, and molecular studies of three patients with constitutional deletions of chromosome 5 in the region of the gene for familial adenomatous polyposis. Am J Hum Genet 50:988-997, 1992
33. Barber JC, Ellis KH, Bowles LV, et al: Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion. J Med Genet 31:312-316, 1994
34. Oshima M, Oshima H, Kobayashi M, et al: Evidence against dominant negative mechanisms of intestinal polyp formation by APC gene mutations. Cancer Res 55:2719-2722, 1995
35. Levy DB, Smith KJ, Beazer-Barclay Y, et al: Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54:5953-5958, 1994
36. Oshima M, Oshima H, Kitagawa K, et al: Loss of APC heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated APC gene. Proc Natl Acad Sci USA 92:4482-4486, 1995
37. Luongo C, Moser AR, Gledhill S, et al: Loss of APC+ in intestinal adenomas from Min mice. Cancer Res 54:5947-5952, 1994
38. Heppner Goss KJ, Tuohy TMF, Groden J: Localization of APC to membrane edges of cells requires the full-length protein. Keystone Symposium: Molecular Mechanisms for Gastrointestinal Cancer, Keystone, CO, April 1-7, 1999, pp 33
39. Neufeld K, Nix D, Beckerle M, et al: The tumor suppressor protein APC contains functional nuclear export signals. Keystone Symposium: Molecular Mechanisms for Gastrointestinal Cancer, Keystone, CO, April 1-7, 1999, pp 34
40. Neufeld KL, White RL: Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc Natl Acad Sci USA 94:3034-3039, 1997
41. Rubinfeld B, Souza B, Albert I, et al: The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. J Biol Chem 270:5549-5555, 1995
42. Behrens J, von Kries JP, Kuhl M, et al: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638-642, 1996
43. Molenaar M, van de Wetering M, Oosterwegel M, et al: XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86:391-399, 1996
44. Huber AH, Nelson WJ, Weis WI: Three-dimensional structure of the armadillo repeat region of beta-catenin. Cell 90:871-882, 1997
45. Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262:1734-1737, 1993
46. Rubinfeld B, Albert I, Porfiri E, et al: Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023-1026, 1996
47. Behrens J, Jerchow BA, Wurtele M, et al: Functional interaction of an axin homolog, conductin, with beta-catenin. APC, and GSK3beta. Science 280:596-599, 1998
48. Kishida S, Yamamoto H, Ikeda S, et al: Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273:10823-10826, 1998
49. Yamamoto H, Kishida S, Uochi T, et al: Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 18:2867-2875, 1998
50. Kitagawa M, Hatakeyama S, Shirane M, et al: An F-box protein, FWD-1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 18:2401-2410, 1999
51. Hart M, Concordet JP, Lassot I, et al: The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9:207-210, 1999
52. Aberle H, Bauer A, Stappert J, et al: Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797-3804, 1997
53. Sparks AB, Morin PJ, Vogelstein B, et al: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134, 1998
54. Hayashi S, Rubinfeld B, Souza B, et al: A Drosophila homolog ot the tumor suppressor gene adenomatous polyposis coli down-regulates beta-eatenin but its zygotic expression is not essential for the regulation of Armadillo. Proc Natl Acad Sci USA 94:242-247, 1997
55. Vleminckx K, Wong E, Guger K, et al: Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an eetopic dorsoanterior axis. J Cell Biol 136:411-420, 1997
56. Smith KJ, Levy DB, Maupin P, et al: Wild-type but not mutant APC associates with the microtuhule cytoskeleton. Cancer Res 54: 3672-3675, 1994
57. Munemitsu S, Souza B, Muller O, et al: The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54:3676-3681, 1994
58. Deka J, Kuhlmann J, Muller O: A domain within the tumor suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau. Eur J Biochem 253:591-597, 1998
59. Su LK, Burrell M, Hill DE, et al: APC binds to the novel protein EB1. Cancer Res 55:2972-2977, 1995
60. Muhua L, Adames NR, Murphy MD, et al: A cytokinesis checkpoint requiring the yeast homologue of an APC-binding protein. Nature 393:487-491, 1998
61. Markham AF, Askham JM, Meredith DM, et al: Studies on the interaction between APC and EB1. Keystone Symposium: Molecular Mechanisms for Gastrointestinal Cancer, Keystone, CO, April 1-7, 1999
62. Nathke IS, Adams CL, Polakis P, et al: The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134:165-179, 1996
63. Juwana JP, Henderikx P, Mischo A, et al: EB/RP gene family encodes tubulin binding proteins. Intl J Cancer 81:275-284, 1999
64. Matsumine A, Ogai A, Senda T, et al: Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 272:1020-1023, 1996
65. Lue RA, Marfatia SM, Branton D, et al: Cloning and characterization of hdlg: The human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1. Proc Natl Acad Sci USA 91:9818-9822, 1994
66. Kornau HC, Schenker LT, Kennedy MB, et al: Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269:1737-1740, 1995
67. Kim E, Niethammer M, Rothschild A, et al: Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature 378:85-88, 1995
68. Bhattacharya G, Boman BM: Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells. Biochem Biophys Res Commun 208:103-110, 1995
69. Bhattacharjee RN, Hamada F, Toyoshima K, et al: The tumor suppressor gene product APC is hyperphosphorylated during the M phase. Biochem Biophys Res Commun 220:192-195, 1996
70. Trzepacz C, Lowy AM, Kordich JJ, et al: Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34. J Biol Chem 272:21681-21684, 1997
71. Huber O, Korn R, McLaughlin J, et al: Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59:3-10, 1996
72. Porfiri E, Rubinfeld B, Albert I, et al: Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin, Oncogene 15:2833-2839, 1997
73. Morin PJ, Sparks AB, Korinek V, et al: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275:1787-1790, 1997
74. Korinek V, Barker N, Morin PJ, et al: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275:1784-1787, 1947
75. Prieve MG, Waterman ML: Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression. Mol Cell Biol 19:4503-4515, 1999
76. Chan EF, Gat U, McNiff JM, et al: A common human skin tumor is caused by activating mutations in beta-catenin. Nat Genet 21:410-413, 1999
77. Caca K, Kolligs FT, Ji X, et al: Beta-and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/ lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 10:369-376, 1999
78. Papkoff J, Rubinfeld B, Schryver B, et al: Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 16:2128-2134, 1996
79. Polakis P: The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9:15-21, 1999
80. Duval A, Gayet J, Zhou XP, et al: Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 59:4213-4215, 1999
81. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512, 1998
82. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426, 1999
83. Crawford HC, Fingleton BM, Rudolph-Owen LR, et al: The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18:2883-2891, 1999
84. Mann B, Gelos M, Siedow A, et al: Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96:1603-1608, 1999
85. Brannon M, Gomperts M, Sumoy L, et al: A beta-catenin/ XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev 11:2359-2370, 1997
86. Cavallo RA, Cox RT, Moline MM, et al: Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 395: 604-608, 1998
87. Roose J, Molenaar M, Peterson J, et al: The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395:608-612, 1998
88. Waltzer L, Bienz M: Drosophila CBP represses the transcription factor TCF to antagonize Wingless signaling. Nature 395:521-525, 1998
89. Roose J, Huls G, van Beest M, et al: Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285: 1923-1926, 1999
90. Groden J, Joslyn G, Samowitz, W, et al: Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55:1531-1539, 1995
91. Baeg GH, Matsumine A, Kuroda T, et al: The tumor suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J 14:5618-5625, 1995
92. McCartney BM, Dierick HA, Kirkpatrick C, et al: Drosophila APC2 is a cytoskeletally-associated protein that regulates wingless signaling in the embryonic epidermis. J Cell Biol 146:1303-1318, 1999
93. Wong MH, Hermiston ML, Syder AJ, et al: Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci USA 93:9588-9593, 1996
94. Moser AR, Shoemaker AR, Connelly CS, et al: Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Devl Dynam 203:422-433, 1995
95. Smith KJ, Johnson KA, Bryan TM, et al: The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90:2846-2850, 1993
96. Korinek V, Barker N, Moerer P, et al: Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379-383, 1998
97. Morin PJ, Vogelstein B, Kinzler KW: Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93:7950-7954, 1996
98. Ahmed Y, Hayashi S, Levine A, et al. Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell 93:1171-1182, 1998
99. Moser AR, Pitot HC, Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324, 1990
100. Su LK, Kinzler KW, Vogelstein B, et al: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670, 1992
101. Fodde R, Edelmann W, Yang K, et al: A targeted chain-termination mutation in the mouse APC gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91:8969-8973, 1994
102. Smits R, Kartheuser A, Jagmohan-Changur S, et al: Loss of APC and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for APC-driven carcinogenesis. Carcinogenesis 18:321-327, 1997
103. Marcus DM, Rustgi AK, Defoe D, et al: Retinal pigment epithelium abnormalities in mice with adenomatous polyposis coli gene disruption. Arch Ophthalmol 115:645-650, 1997
104. Smits R, van der Houven van Oordt W, Luz A, et al: Apc1638N: A mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114:275-283, 1998
105. Shibata H, Toyama K, Shioya H, et al: Rapid colorectal adenoma formation initiated by conditional targeting of the APC gene. Science 278:120-123, 1997
106. Jacoby RF, Marshall DJ, Newton MA, et al: Chemoprevention of spontaneous intestinal adenomas in the Ape Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 56: 710-714, 1996
107. Ritland S, Gendler SJ: Chemoprevention of intestinal adenomas in the APC Min mouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression. Carcinogenesis 20:51-58, 1999
108. Boolbol SK, Dannenberg AJ, Chadburn A, et al: Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556-2560, 1996
109. Mahmoud NN, Boolbol SK, Dannenberg AJ, et al: The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 19:87-91, 1998
110. Potter JD: Colorectal cancer: Molecules and populations. J Natl Cancer Inst 91:916-932, 1999
111. Giardiello FM, Hamilton SR, Krush AJ, et al: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313-1316, 1993
112. Giardiello FM, Offerhaus JA, Tersmette AC, et al: Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: Evaluation of predictive factors. Gut 38:578-581, 1996
113. Oshima M, Dinchuk JE, Kargman SL, et al: Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803-809, 1996
114. Williams CS, Luongo C, Radhika A, et al: Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111:1134-1140, 1996
115. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell 83:493-501, 1995
116. Tsujii M, Kawano S, Tsuji S, et al: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716, 1998
117. Carlson M, Prescott S: The high mobility group transcription factor Lef-1 can activate cyclo0xygenase-2 transcription in colon cancer cell lines. Keystone Symposium: Molecular Mechanisms for Gastrointestinal Cancer, Keystone, CO, April 1-7, 1999, pp 44
118. Goss KJ, Brown PD, Matrisian LM: Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Intl J Cancer 78:629-635, 1998
119. Kennedy AR, Bearer-Barclay Y, Kinzler KW, et al: Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res 56:679-682, 1996
120. Laird PW, Jackson-Grusby L, Fazeli A, et al: Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205, 1995
121. Arenas RB, Fichera A, Mok P, et al: Introduction of human adenomatous polyposis coli gene into Min mice via cationic liposomes. Surgery 120:712-717, 1996
122. Hargest R, Eldin A, Williamson R: Gene therapy for familial adenomatous polyposis: Prolonged expression of the adenomatous polyposis coli gene after lipofection into mouse colon in vivo. Adv Exp Med Biol 451:382-391, 1998